Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07562997 · ClinicalTrials.gov registry record · NA
Sodium and Milk Fortification Evaluation of Body Composition Among Very Preterm Infants
A NA study, sponsored by University of Washington.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
NCT07562997: Recruiting NA study, sponsored by University of Washington.
NCT07562997 is a NA study that is actively recruiting participants, run by University of Washington. The registered enrollment target is 150 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07562997, a NA study, is actively recruiting participants, sponsored by University of Washington.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
Study Summary
The goal of the trial is to learn if targeted sodium supplementation (including blood and urine sodium testing) versus standard milk fortification (including blood sodium testing) improves growth and body composition in very preterm infants?
Primary Outcome
Evaluate muscle and subcutaneous fat accretion from enrollment to 36 weeks posmtnestrual age. The study team will perform biceps and rectus femoris cross-sectional area measurements using point-of-care ultrasound every 2 weeks. We will perform arm and mid-thigh subcutaneous fat measurements using point-of-care ultrasound every 2 weeks.
Interventions
- DIAGNOSTIC_TEST Urine sodium testing
- DIAGNOSTIC_TEST Serum sodium testing
- DIETARY_SUPPLEMENT Milk fortification
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2026-05-18 |
| Est. Completion | 2029-10-31 |
| Phase | NA |
What NCT07562997 shows while recruiting
NCT07562997 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).
The record links to 0 conditions, and to 3 interventions - of which Urine sodium testing is the first listed.
NCT07562997 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07562997 about?
NCT07562997 is a clinical study titled "Sodium and Milk Fortification Evaluation of Body Composition Among Very Preterm Infants". The goal of the trial is to learn if targeted sodium supplementation (including blood and urine sodium testing) versus standard milk fortification (including blood sodium testing) improves growth and body composition in very preterm infants?
What is the current status of trial NCT07562997?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2026-05-18. Estimated completion is 2029-10-31.
What interventions are being tested in trial NCT07562997?
The interventions under investigation include: Urine sodium testing (DIAGNOSTIC_TEST), Serum sodium testing (DIAGNOSTIC_TEST), Milk fortification (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07562997?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07562997's enrollment target sits among peer trials
150 661st of 2000 higher than 1,299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI